Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
The Pending NDC and Barcode Rule: Healthcare IT Company Perspectives
With the Food and Drug Administration’s (FDA) final rule covering amendments to its National Drug Code (NDC)1 and barcode rules anticipated in early 2024, it is essential for organizations throughout the supply chain to prepare for this regulation.
We continue our review of comments to the FDA’s proposal by summarizing responses submitted by organizations within the healthcare IT industry.
